MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 6, 2005; DOI: 10.1124/mol.105.014670


0026-895X/05/6803-793-799$20.00
Mol Pharmacol 68:793-799, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.014670v1
68/3/793    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tavernier, G.
Right arrow Articles by Langin, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tavernier, G.
Right arrow Articles by Langin, D.

Norepinephrine Induces Lipolysis in {beta}1/{beta}2/{beta}3-Adrenoceptor Knockout Mice

Geneviève Tavernier, Maria Jimenez, Jean-Paul Giacobino, Nicolas Hulo, Max Lafontan, Patrick Muzzin, and Dominique Langin

Unité de Recherches sur les Obésités, Inserm UPS U586, Institut Louis Bugnard, Centre Hospitalier Universitaire de Rangueil, Toulouse, France (G.T., M.L., D.L.); Départements de Biochimie Médicale et de Physiologie Cellulaire et Métabolisme, Centre Médical Universitaire, Genève, Switzerland (M.J., J.-P.G., P.M.); and Swiss Institute of Bioinformatics, Centre Médical Universitaire, Genève, Switzerland (N.H.)

Catecholamines are major stimulants of adipose tissue metabolism. Norepinephrine and epinephrine act through three subtypes of {beta}-adrenoceptors ({beta}-AR) expressed in the adipocytes. The aim of this work was to study the mechanisms of lipid mobilization in {beta}1/{beta}2/{beta}3-AR triple-knockout ({beta}-less) mice. Glycerol and nonesterified fatty acids released from isolated adipocytes were measured as an index of lipolytic activity. There was no difference between the two genotypes for basal lipolysis and lipolytic response to corticotropin or to agents acting at the adenylyl cyclase and protein kinase A levels. The lipolytic response to norepinephrine and {beta}-AR agonists was blunted in {beta}-less mice. However, a residual low-affinity lipolytic effect was observed in the presence of catecholamines and {beta}3-AR agonists but not of {beta}1- or {beta}2-AR agonists. cAMP levels were increased by a {beta}-AR agonist in white and brown adipocytes of {beta}-less mice. The residual lipolytic effect was blocked by {beta}-AR antagonists. It was mediated neither by {alpha}1- or {alpha}2-AR nor dopaminergic, serotonergic, and histaminergic by receptors. Bioinformatic analyses do not provide evidence for a fourth {beta}-AR. We conclude that the residual lipolytic effect observed in {beta}-less mice can be attributed to an unknown Gs-protein-coupled receptor with low affinity for catecholamines.


Received May 11, 2005; accepted June 6, 2005

Address correspondence to: Dr. G. Tavernier, Unité de Recherches sur les Obésités, Inserm UPS U586, Institut Louis Bugnard IFR31, CHU Rangueil, Batiment L3, BP 84225, 31432 Toulouse Cedex 4, France. E-mail: getaver{at}toulouse.inserm.fr




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
T. J. Bartness and C. K. Song
Thematic review series: Adipocyte Biology. Sympathetic and sensory innervation of white adipose tissue
J. Lipid Res., August 1, 2007; 48(8): 1655 - 1672.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Miura, K. Kawanaka, Y. Kai, M. Tamura, M. Goto, T. Shiuchi, Y. Minokoshi, and O. Ezaki
An Increase in Murine Skeletal Muscle Peroxisome Proliferator-Activated Receptor-{gamma} Coactivator-1{alpha} (PGC-1{alpha}) mRNA in Response to Exercise Is Mediated by {beta}-Adrenergic Receptor Activation
Endocrinology, July 1, 2007; 148(7): 3441 - 3448.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics